Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pramipexole makes a difference to the QOL of patients with restless leg syndrome

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Högl B, Poewe W, Garcia-Borreguero D, Ferini-Strambi L, Trenkwalder C.26-weeks of pramipexole on quality of life in restless legs syndrome. 13th International Congress of Parkinson's Disease and Movement Disorders: 440 abstr. Tu-315, 7 Jun 2009. Available from: URL: http://www.movementdisorders.org

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Pramipexole makes a difference to the QOL of patients with restless leg syndrome. Pharmacoecon. Outcomes News 581, 10 (2009). https://doi.org/10.2165/00151234-200905810-00031

    Download citation

    Keywords

    • Placebo
    • Health Survey
    • Movement Disorder
    • Placebo Recipient
    • Bodily Pain